pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CRO/CDMO · news · pharmadog
← back to CRO/CDMO
News · CRO/CDMO
103
stories
Aug 6, 26
CROs vs. biotechs: Finding the right fit
biospace
Aug 5, 26
In a first, WuXi AppTec surpasses Lonza’s six-month revenue
endpoints
Aug 5, 26
Over 1/3 stay in biopharma jobs for health insurance, poll finds
biospace
Aug 4, 26
Icon inks Anthropic partnership to deploy Claude into clinical trials
fiercebiotech
Aug 4, 26
Lisata lays off 72% of staffers, sues Kuva after planned merger falls apart
fiercebiotech
Aug 4, 26
KKR inks $5.7B deal to take medtech manufacturing giant Integer private
fiercebiotech
Aug 3, 26
Biologics push CMOs/CDMOs to expand sterile fill-finish and prefilled syringe capacity
biospace
Aug 3, 26
Biotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls out
biospace
Jul 31, 26
Lilly and Resilience invest $750M in diabetes and obesity drug device supply
biospace
Jul 31, 26
Resilience and Lilly invest $750M to boost Cincinnati drug production
biopharma dive
Jul 30, 26
Daiichi’s pipeline falls behind rivals as cash flow nears peak: analysts
biospace
Jul 30, 26
Not-so-special delivery: When biopharmas fumble layoff news
biospace
Jul 29, 26
Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR-T therapy
biospace
Jul 28, 26
The FDA was all in on AI. Will that change?
biopharma dive
Jul 28, 26
Acrosian debuts as AI-focused biometrics CRO
fiercebiotech
Jul 28, 26
As pharma descends on China for deals, BIOSECURE Act raises intellectual property risk
biospace
Jul 27, 26
From confidence to capital: Positioning biotech for the next growth cycle
biopharma dive
Jul 27, 26
FDA has recommitted to adcomms—but to what end?
biospace
Jul 23, 26
From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotech
fiercebiotech
Jul 23, 26
Repligen’s $1.5B buy for BioLife; BeOne’s $300M US expansion
endpoints
Jul 23, 26
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
biospace
Jul 22, 26
House passes bill directing FDA to update animal testing rules
fiercebiotech
Jul 21, 26
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
biospace
Jul 20, 26
Samsung Bio to step into peptides in $1.8B buy for PolyPeptide
endpoints
Jul 16, 26
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
biospace
Jul 15, 26
Insilico, Bora Pharma reveal plans for AI-driven manufacturing company
endpoints
Jul 9, 26
Catalent to divest UK site; Rottendorf, Evonik announce manufacturing builds
endpoints
Jul 2, 26
Galderma gets CRL for anti-wrinkle drug; Kimball buys CDMO for $103M
endpoints
Jul 2, 26
STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong
stat
Jun 30, 26
Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot program
biopharma dive
← prev
page 3 of 4
next →
